Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients-Reference-Cited by-同舟云学术

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

Published:2013 Issue:1 Volume:11 Page:145
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:Journal of Translational Medicine

Author:

Ascierto Maria,Idowu Michael O,Zhao Yingdong,Khalak Hanif,Payne Kyle K,Wang Xiang-Yang,Dumur Catherine I,Bedognetti Davide,Tomei Sara,Ascierto Paolo A,Shanker Anil,Bear Harry D,Wang Ena,Marincola Francesco M,De Maria Andrea,Manjili Masoud H

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference48 articles.

1. An immunologic portrait of cancer

2. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

3. In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

4. Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes

5. A signature of immune function genes associated with recurrence-free survival in breast cancer patients

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity;Advanced Biology;2024-05-10

2. Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer;Cancer Immunology, Immunotherapy;2024-05-07

3. Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review;Medical Oncology;2024-03-27

4. Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma;Aging;2024-03-07

5. Efficacy and safety of natural killer cells injection combined with XELOX chemotherapy in postoperative patients with stage III colorectal cancer in China: a prospective randomised controlled clinical trial study protocol;BMJ Open;2024-03